f | { | f | { |
n | | n | "author": "", |
| | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "c7847d0e-4c38-4c36-82c2-b848fc56f59d", | | "id": "c7847d0e-4c38-4c36-82c2-b848fc56f59d", |
| "isopen": false, | | "isopen": false, |
n | "license_title": null, | n | "license_id": "notspecified", |
| | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:11:54.622995", | | "metadata_created": "2021-09-16T08:11:54.622995", |
n | "metadata_modified": "2022-04-05T00:51:03.829621", | n | "metadata_modified": "2022-04-27T07:36:21.772363", |
| "name": "malawi-integrated-hiv-program-report-2013-q3", | | "name": "malawi-integrated-hiv-program-report-2013-q3", |
n | | n | "notes": "This is the 9th quarterly HIV Program report after |
| | | implementation of the 2011 Integrated Clinical\r\nHIV Guidelines in |
| | | July 2011. A summary of the key achievements between July and |
| | | September\r\n2013 is provided below:\r\n\r\n* Scale-up of integrated |
| | | HIV services had reached the following number of sites:\r\n\r\n * |
| | | __825__ static (607 within and 218 outside of health facilities) and |
| | | 534 outreach HTC sites\r\n\r\n * __675__ (static) ART |
| | | sites\r\n\r\n * __590__ PMTCT sites (Option B+)\r\n\r\n * |
| | | __628__ Pre-ART sites\r\n\r\n * __605__ sites with HIV-exposed |
| | | child follow-up\r\n\r\n* __405,278__ persons were tested and |
| | | counselled for HIV and __36,807 (9%)__ were HIV positive;\r\n__145,572 |
| | | (36%)__ people tested for the first time.\r\n\r\n* __12,646 (95%)__ of |
| | | __13,299__ blood units collected were screened for HIV, hepatitis B |
| | | and syphilis.\r\n\r\n* __128,022 (83%)__ of __153,561__ women at ANC |
| | | had their HIV status ascertained; 9,988 (8%) of\r\nthese were HIV |
| | | positive. __122,392 (93%)__ of __132,279__ women at maternity had |
| | | their HIV status\r\nascertained; __9,337 (8%)__ of these were HIV |
| | | positive.\r\n\r\n* __25,551__ patients started ART during this |
| | | quarter; this is similar to the previous quarter\r\n(26,802).\r\n\r\n* |
| | | __459,261__ patients were alive and on ART by end of September 2013. |
| | | This is equivalent to\r\n74% coverage of the estimated __602,000__ |
| | | population in need of ART (all ages).1 Estimated ART\r\ncoverage among |
| | | children (<15 years) and adults was 47% and 81%, |
| | | respectively.\r\n\r\n* __78%__ of adults and __80%__ of children were |
| | | retained alive on ART at 12 months after initiation.\r\n\r\n* |
| | | __309,127 (73%)__ of __424,961__ on first line adult ART were on |
| | | regimen 5A (TDF/3TC/EFV).\r\n\r\nThe proportion of ART patients with |
| | | documented side effects declined from 7% to 2%\r\ncompared with the |
| | | previous quarter.\r\n\r\nA total of __11,788__ HIV positive pregnant |
| | | women were on ART: __5,041 (43%)__ of these were\r\nalready on ART |
| | | when getting pregnant and 6,747 (57%) started ART |
| | | during\r\npregnancy/delivery. This is equivalent to 75% ART coverage |
| | | among the estimated 15,750\r\nHIV infected pregnant women in Malawi |
| | | this quarter. __6,429 (95%)__ of pregnant women\r\nstarted ART due to |
| | | Option B+ (in WHO clinical stage 1 or 2) and 318 (5%) due to a low |
| | | CD4\r\ncount and/or WHO clinical stage 3 or 4.\r\n\r\n* An additional |
| | | __1,831__ breastfeeding women started ART due to Option B+ (in WHO |
| | | stage 1/2)\r\n\r\n* __6,057 (79%)__ of __7,677__ women started under |
| | | Option B+ were retained at 6 months after ART\r\ninitiation; __6,630 |
| | | (72%)__ of __9,205__ were retained at 12 months after ART |
| | | initiation.\r\n\r\n* __8,564 (7%)__ of infants discharged alive from |
| | | maternity were known to be HIV exposed, 7,941\r\n(93%) of these |
| | | received ARV prophylaxis (nevirapine). __5,734 (67%)__ were enrolled |
| | | in exposed\r\nchild follow-up before age 2 months.\r\n\r\n* A total of |
| | | __10,258__ HIV exposed children and __8,884__ pre-ART patients were |
| | | enrolled for followup\r\nin HIV Care Clinics (HCC) during this |
| | | quarter.\r\n\r\n* __162__ medical staff were newly trained and |
| | | certified in PMTCT/ART this quarter. This brings\r\nthe total number |
| | | trained in the 2011 guidelines to __5,985__.\r\n\r\n* __1,243__ HTC |
| | | providers were re-trained using the HTC Skills Intensive Training |
| | | curriculum,\r\nbringing the total number re-trained to |
| | | __3,776__.\r\n\r\n* A total of __921__ staff at __235__ sites in 19 |
| | | districts received clinical mentoring during. 104 staff\r\ngraduated, |
| | | __250__ were in intensive and __350__ in continuation phase this |
| | | quarter.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
n | "description": "Department of HIV & AIDS and Viral Hepatitis", | n | "description": "The Department of HIV & AIDS (DHA) was established |
| | | in 2001, initially as a unit in the Department of Clinical Services, |
| | | to coordinate the biomedical HIV Program in Malawi. The department now |
| | | carries responsibility for various HIV related programs including: |
| | | sexually transmitted infections (STIs), prevention of mother to child |
| | | transmission of HIV (PMTCT), and national voluntary male medical |
| | | circumcision program (VMMC). All these HIV program sub-sections are |
| | | linked to one robust monitoring and evaluation sub-section in the HIV |
| | | and AIDS Department which technically operates under the Central |
| | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
n | "image_url": "", | n | "image_url": |
| | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
t | "title": "Department of HIV & AIDS", | t | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:55:50.966085", | | "created": "2022-03-23T19:55:50.966085", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "f07b68b7-2868-499c-adc9-51fb8192dae2", | | "id": "f07b68b7-2868-499c-adc9-51fb8192dae2", |
| "last_modified": "2022-04-05T00:51:03.821849", | | "last_modified": "2022-04-05T00:51:03.821849", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2013-q3", | | "dha/malawi-integrated-hiv-program-report-2013-q3", |
| "metadata_modified": "2022-04-05T00:51:03.833627", | | "metadata_modified": "2022-04-05T00:51:03.833627", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2013-q3", | | "name": "malawi-integrated-hiv-program-report-2013-q3", |
| "package_id": "c7847d0e-4c38-4c36-82c2-b848fc56f59d", | | "package_id": "c7847d0e-4c38-4c36-82c2-b848fc56f59d", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "a80245286d2b058cd7dd72acb676d7b9ad8c16fe36f5ff111a07805f30a3e980", | | "a80245286d2b058cd7dd72acb676d7b9ad8c16fe36f5ff111a07805f30a3e980", |
| "size": 1970627, | | "size": 1970627, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| fb8192dae2/download/malawi-integrated-hiv-program-report-2013-q3.pdf", | | fb8192dae2/download/malawi-integrated-hiv-program-report-2013-q3.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2013 Q3", | | "title": "Malawi Integrated HIV Program Report 2013 Q3", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2013" | | "year": "2013" |
| } | | } |